Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma ...

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton ...

The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies, today announced U.S ...

According to the American Cancer Society, it is estimated that more than two million new cancer cases will be diagnosed and ...

The firms will screen compounds from natural sources for activity against gene variants linked to chronic diseases.